Liquid biopsy has emerged as a promising avenue for non‐invasive and rapid retrieval of
pathological information from patient body fluids. Over the years, liquid biopsy has garnered …

Microfluidic systems have been investigated as practical tools in the fields of biomedical
engineering, analytical chemistry, materials science, and biological research. Yet the …

Small extracellular vesicles (sEVs;< 200 nm) that contain lipids, nucleic acids, and proteins
are considered promising biomarkers for a wide variety of diseases. Conventional methods …

Tumor‐derived circulating extracellular vesicles (EVs) provide a non‐invasive solution for
cancer diagnostics, but hampered by challenges in EVs isolation and profiling. Herein, this …

Tumor-derived extracellular vesicles (tEVs) hold immense promise as potential biomarkers
for the precise diagnosis of hepatocellular carcinoma (HCC). However, their clinical …

Cell-free RNAs and extracellular vesicles (EVs) are valuable biomarkers in liquid biopsies,
but they are prone to preanalytical variabilities such as nonstandardized centrifugation or ex …

The early-stage diagnosis of cancer is a crucial clinical need. The inadequacies of surgery
tissue biopsy have prompted a transition to a less invasive profiling of molecular biomarkers …

Triple-negative breast cancer (TNBC) is a highly metastatic and heterogeneous type of
breast cancer with poor outcomes. Precise, non-invasive methods for diagnosis, monitoring …

Liquid biopsy is of great significance in tumor early diagnosis and treatment stratification. PD-
L1-positive small extracellular vesicles (PD-L1+ sEVs) are closely related to tumor growth …

Tumor extracellular vesicles (EVs) demonstrate considerable promise for medication
delivery and tumor targeting owing to their natural long-term blood circulation and tissue …